Back to HomeBeta

ICD-10 Coding for Hypercoagulability(D68.51, D68.69)

Complete ICD-10-CM coding and documentation guide for Hypercoagulability. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

ThrombophiliaCoagulation Disorder

Related ICD-10 Code Ranges

Complete code families applicable to Hypercoagulability

D68.5-D68.6Primary Range

Coagulation Defects

This range includes codes for both inherited and acquired hypercoagulable states.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
D68.51Activated protein C resistanceUse when genetic testing confirms Factor V Leiden mutation.
  • Genetic testing confirming Factor V Leiden mutation
D68.69Other thrombophiliaUse when hypercoagulability is secondary to another condition like malignancy.
  • Documentation linking hypercoagulability to an underlying condition

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for hypercoagulability

Essential facts and insights about Hypercoagulability

The ICD-10 code for hypercoagulability includes D68.51 for inherited and D68.69 for secondary conditions.

Primary ICD-10-CM Codes for hypercoagulability

Activated protein C resistance
Billable Code

Decision Criteria

clinical Criteria

  • Genetic confirmation of Factor V Leiden mutation

Applicable To

  • Factor V Leiden mutation

Excludes

  • Antiphospholipid syndrome (D68.62)

Clinical Validation Requirements

  • Genetic testing confirming Factor V Leiden mutation

Code-Specific Risks

  • Misuse without genetic confirmation

Coding Notes

  • Ensure genetic confirmation before coding.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Embolism and thrombosis of unspecified vein

I82.90
Use with D68.69 when there is a documented thrombotic event.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Antiphospholipid syndrome

D68.62
Use D68.62 when antiphospholipid antibodies are present.

Long term (current) use of anticoagulants

Z79.01
Use Z79.01 for anticoagulant use without hypercoagulability.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Hypercoagulability to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D68.51.

Impact

Clinical: Leads to vague diagnosis and treatment plans., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials.

Mitigation Strategy

Specify if the disorder is inherited or acquired., Link to specific conditions when applicable.

Impact

Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records.

Mitigation Strategy

Ensure clinical documentation supports hypercoagulability diagnosis.

Impact

Using D68.69 without documented secondary cause.

Mitigation Strategy

Ensure documentation clearly links hypercoagulability to a secondary condition.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Hypercoagulability, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Hypercoagulability

Use these documentation templates to ensure complete and accurate documentation for Hypercoagulability. These templates include all required elements for proper coding and billing.

Secondary hypercoagulable state due to malignancy

Specialty: Oncology

Required Elements

  • Diagnosis of malignancy
  • Description of thrombotic events
  • Link between malignancy and hypercoagulability

Example Documentation

Patient presents with DVT due to pancreatic cancer. Documented as 'Secondary hypercoagulable state due to active pancreatic adenocarcinoma.'

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has a clotting disorder.
Good Documentation Example
Patient has a secondary hypercoagulable state due to active pancreatic adenocarcinoma.
Explanation
The good example specifies the cause of the hypercoagulable state, allowing for accurate coding.

Need help with ICD-10 coding for Hypercoagulability? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more